- Home
- TNK vs IMCR Comparison
TNK vs IMCR Comparison
Compare TNK & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNK
- IMCR
- Stock Information
- Founded
- TNK 2007
- IMCR 2008
- Country
- TNK Bermuda
- IMCR United Kingdom
- Employees
- TNK N/A
- IMCR N/A
- Industry
- TNK Marine Transportation
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TNK Consumer Discretionary
- IMCR Health Care
- Exchange
- TNK Nasdaq
- IMCR Nasdaq
- Market Cap
- TNK 1.8B
- IMCR 1.7B
- IPO Year
- TNK 2007
- IMCR 2021
- Fundamental
- Price
- TNK $51.45
- IMCR $34.21
- Analyst Decision
- TNK Buy
- IMCR Buy
- Analyst Count
- TNK 3
- IMCR 9
- Target Price
- TNK $50.67
- IMCR $57.00
- AVG Volume (30 Days)
- TNK 503.3K
- IMCR 286.9K
- Earning Date
- TNK 10-29-2025
- IMCR 11-05-2025
- Dividend Yield
- TNK 3.89%
- IMCR N/A
- EPS Growth
- TNK N/A
- IMCR N/A
- EPS
- TNK 8.13
- IMCR N/A
- Revenue
- TNK $997,294,000.00
- IMCR $356,145,000.00
- Revenue This Year
- TNK N/A
- IMCR $29.67
- Revenue Next Year
- TNK $10.09
- IMCR $11.12
- P/E Ratio
- TNK $6.33
- IMCR N/A
- Revenue Growth
- TNK N/A
- IMCR 26.78
- 52 Week Low
- TNK $33.35
- IMCR $23.15
- 52 Week High
- TNK $62.45
- IMCR $39.33
- Technical
- Relative Strength Index (RSI)
- TNK 50.90
- IMCR 48.79
- Support Level
- TNK $49.48
- IMCR $33.90
- Resistance Level
- TNK $55.18
- IMCR $37.00
- Average True Range (ATR)
- TNK 1.27
- IMCR 1.54
- MACD
- TNK -0.62
- IMCR 0.04
- Stochastic Oscillator
- TNK 31.77
- IMCR 39.35
About TNK Teekay Tankers Ltd.
Teekay Tankers Ltd is a provider of marine services to the international oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: Tankers, which consists of the operation of all of the company's tankers (including the operations from those tankers employed on full service lightering contracts), and the company's U.S. based ship-to-ship support service operations (including its lightering support services provided as part of full service lightering operations); and Marine Services, which consists of operational and maintenance marine services provided to the Australian government, Australian energy companies and other third parties. The company generates the majority of its revenue from the Tankers segment.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.